![Feng Zhan Zhang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Feng Zhan Zhang
Contatto Relazioni con gli Investitori presso SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD
Provenienza dei contatti di primo grado di Feng Zhan Zhang
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
UBS Securities Co. Ltd.
![]() UBS Securities Co. Ltd. Investment Banks/BrokersFinance UBS Securities Co. Ltd. is the Chinese brokerage subsidiary of UBS Group AG (SWX: UBSG) in Switzerland. Headquartered in Beijing, the firm was founded in 2006 as Beijing Securities Co. Ltd. They provide securities brokerage services to domestic corporate and institutional clients, and qualified foreign institutional investors (QFII).
118
| Subsidiary | Investment Banks/Brokers | 118 |
Public Company | Pharmaceuticals: Major | 18 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Feng Zhan Zhang tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Washington University in St. Louis | College/University | Graduate Degree | |
3SBIO INC. | Biotechnology | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Corporate Secretary | |
Goldman Sachs (Singapore) Pte.
![]() Goldman Sachs (Singapore) Pte. Investment Banks/BrokersFinance Goldman Sachs (Singapore) Pte. (Goldman Sachs-Singapore) is the brokerage subsidiary of New York-based Goldman Sachs Group, Inc. (NYSE: GS), a global investment bank that offers financial services to corporations, institutions, governments and high-net worth individuals. Headquartered in Singapore, the firm opened in 1989 and is the regional hub for the group's activities in Southeast Asia, particularly asset management and energy trading. Goldman Sachs-Singapore provides a full range of corporate finance and capital markets products and services across a wide range of operating areas. Business functions include capital structuring advisory, and security services. | Investment Banks/Brokers | Analyst-Equity | |
BENGANG STEEL PLATES CO., LTD. | Steel | Director/Board Member | |
ANGANG STEEL COMPANY LIMITED | Steel | Director/Board Member | |
Credit Suisse (Hong Kong) Ltd.
![]() Credit Suisse (Hong Kong) Ltd. Investment Banks/BrokersFinance Credit Suisse (Hong Kong) Ltd. (CSHK) is a securities brokerage firm headquartered Hong Kong. The firm is a subsidiary of Credit Suisse AG, which is owned by Credit Suisse Group AG (SWX: CSGN; ADR: CS) in Switzerland. CSHK provides corporate and institutional investors with sales, trading, financing, prime services, and market-making in global equities, as well as equities-related securities, options, futures, risk management, and hedging products. Their client-focused platform offers issuer and investor clients access to distribution, trading, and origination capabilities across various markets globally. | Investment Banks/Brokers | Analyst-Equity | |
LUENMEI QUANTUM CO.,LTD | Alternative Power Generation | Director/Board Member | |
Merrill Lynch Far East Ltd.
![]() Merrill Lynch Far East Ltd. Investment Banks/BrokersFinance Merrill Lynch Far East Ltd. is the stockbroking subsidiary of Merrill Lynch HK Services Ltd., ultimately owned by Bank of America Corp. (NYSE: BAC) in the US. Headquartered in Hong Kong, the firm was founded in 2003 and offers a broad range of brokerage services to institutional investors. | Investment Banks/Brokers | Analyst-Equity | |
CHINA TOURISM GROUP DUTY FREE CORPORATION LIMITED | Discount Stores | Director/Board Member | |
LIAONING SHENHUA HOLDINGS CO.,LTD | Motor Vehicles | Director/Board Member | |
BOC International (China) Ltd. (Broker)
![]() BOC International (China) Ltd. (Broker) Investment Banks/BrokersFinance BOC International (China) Ltd. (Broker) (BOC Broker) is the brokerage division of BOC International (China) Ltd. The firm is headquartered in Shanghai and was founded in 2002. BOC Broker provides brokerage services to their clients. | Investment Banks/Brokers | Analyst-Equity | |
China International Capital Corp. Ltd. (Broker)
![]() China International Capital Corp. Ltd. (Broker) Investment Banks/BrokersFinance China International Capital Corp. Ltd. (Broker) (CICC) is the brokerage division of China International Capital Corp. Ltd. which was established in 1995 as a strategic partnership between Chinese and international financial institutions and corporations. Headquartered in Beijing, CICC was the first joint venture investment bank in China. The firm's core business departments were investment banking, capital markets, sales & trading, research, fixed-income and asset management. CICC offers a range of brokerage services to international and domestic institutional and individual investors. In 2007 the firm set up a wholly-owned subsidiary specializing in private equity investments and focusing on buyout opportunities within China. | Investment Banks/Brokers | Market Strategist Analyst-Equity Analyst-Equity | |
China Europe International Business School | College/University | Masters Business Admin Masters Business Admin | |
Shanghai University of Finance & Economics
![]() Shanghai University of Finance & Economics Other Consumer ServicesConsumer Services Shanghai University of Finance and Economics engages in the provision of educational services. It offers courses under the following school and departments: business, accountancy, finance, international business administration, economics, public economics and administration, humanities, law, information management and engineering, statistics, foreign languages, mathematics, international cultural exchange, professional and international education and continuing education. The company was founded in 1917 and is headquartered in Shanghai, China. | College/University | Undergraduate Degree | |
Yuanta Securities Investment Consulting Co., Ltd.
![]() Yuanta Securities Investment Consulting Co., Ltd. Investment Banks/BrokersFinance Part of Yuanta Financial Holding Co. Ltd., Yuanta Securities Investment Consulting Co., Ltd. is a financial services company based in Taipei, Taiwan. Yuanta Securities Investment Consulting Co. is committed to innovation in products and services, using artificial intelligence and big data technology to provide intelligent stock selection and order placement tools, creating a one-stop mobile service for purchasing, and actively expanding business in Taiwan, China, and Hong Kong, with the aim of becoming the leading securities firm in Asia for Chinese people. The Taiwanese company also offers regular and fixed purchases of US stocks, with a maximum handling fee of only $1, making it easy for customers to become international shareholders. The company was founded in 1961. Vincent Chen has been the CEO of the company since 2011. | Investment Banks/Brokers | Analyst-Equity | |
DBS Vickers (Hong Kong) Ltd.
![]() DBS Vickers (Hong Kong) Ltd. Investment Banks/BrokersFinance DBS Vickers (Hong Kong) Ltd. (DBS-HK) is a broker/dealer firm headquartered in Hong Kong. The firm is a subsidiary of DBS Vickers Securities Holdings Pte Ltd., ultimately held by DBS Group Holdings Ltd. (SGX: D05) in Singapore. DBS-HK provides a comprehensive blend of brokerage services. | Investment Banks/Brokers | Analyst-Equity | |
UBS Securities (Asia) Ltd.
![]() UBS Securities (Asia) Ltd. Investment Banks/BrokersFinance UBS Securities Asia Ltd. (UBS Asia) is a brokerage firm headquartered in Hong Kong. The firm is a subsidiary of UBS AG, which is owned by UBS Group AG (SWX: UBSG) in Switzerland. UBS Asia provides corporate and institutional clients which include intermediary and alternative asset managers with financial advisory services, access to the world's capital markets and securities products and research in the field of equity, fixed-income, rates, foreign exchange, energy and metals. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Corporate Officer/Principal Analyst-Equity | |
Deutsche Bank AG (Hong Kong)
![]() Deutsche Bank AG (Hong Kong) Investment Banks/BrokersFinance Part of Deutsche Bank AG, Deutsche Bank AG (Hong Kong) is a financial institution that has been connecting worlds for 65 years. The company is based in Hong Kong, Hong Kong, and serves as the hub for corporate and commercial clients. The company's asset management division, DWS, is a market leader in Hong Kong with a broad product offering. Its corporate bank division is an established market leader in transaction banking, with a presence in 60 countries, including an extensive footprint in HK. The investment bank provides strategic advice to corporate and institutional clients, focusing on the bank’s traditional strengths in financing, advisory, fixed income, and currencies, together with a focused equity capital markets business. The private bank focuses on private customers across all segments as well as business clients, and in HK, this division is represented by a highly competitive wealth manager. The Chinese company was founded in 1958, and its CEO is Werner Steinmüller. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity Analyst-Equity | |
Goldman Sachs (Asia) LLC
![]() Goldman Sachs (Asia) LLC Investment Banks/BrokersFinance Goldman Sachs (Asia) LLC (GS-Asia) is the Hong Kong-based brokerage subsidiary of Goldman Sachs Holdings (Hong Kong) Ltd., ultimately owned by The Goldman Sachs Group, Inc. (NYSE: GS), a multinational investment bank and financial services company headquartered in New York City. Founded in 1984, GS-Asia provides market insight, risk management and execution services to institutional clients which includes asset managers, hedge funds, banks and brokerages, pensions, endowments and foundations, corporations, and governments. | Investment Banks/Brokers | Analyst-Equity | |
Yuanta Securities (Hong Kong) Co., Ltd.
![]() Yuanta Securities (Hong Kong) Co., Ltd. Investment Banks/BrokersFinance Yuanta Securities (Hong Kong) Co., Ltd. (YSHK) is a brokerage firm headquartered in Hong Kong. The firm is a wholly-owned subsidiary of Yuanta Securities Asia Financial Services Ltd., ultimately owned by Yuanta Financial Holding Co. Ltd. (TPE: 2885) in Taiwan. YSHK provides brokerage services to global and local institutional clients, corporate clients as well as individual investors. | Investment Banks/Brokers | Analyst-Equity | |
Deutsche Bank AG (China) | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Beijing Technology & Business University | College/University | Graduate Degree | |
SWS Research Co., Ltd.
![]() SWS Research Co., Ltd. Investment ManagersFinance SWS Research Co., Ltd. is the investment research subsidiary of Shenwan Hongyuan Securities Co., Ltd., which is owned by Shenwan Hongyuan Group Co., Ltd. (SHE: 000166) in China. Headquartered in Shanghai, the firm was founded in 1992 to offer a wide range of products and services to global investors who want to invest in Chinese equity market. SWS Research provides clients with securities research service that covers over 500 key stocks in Asian market, as well as economics, strategy, bond, fund and derivatives research. Their clients include almost all major domestic institutional investors such as mutual funds, insurance companies, banks and trusts. They also serve QFII and other overseas institutional investors. | Investment Managers | Analyst-Equity Analyst-Equity | |
Beijing Gao Hua Securities Co., Ltd.
![]() Beijing Gao Hua Securities Co., Ltd. Investment Banks/BrokersFinance Beijing Gao Hua Securities Co., Ltd. is a financial services company based in Beijing, China. and has subsidiaries in China. The company's description is written in Chinese, but it appears to offer a range of financial services, including securities trading, investment banking, and asset management. The private company's website includes information about its history, services, and team, as well as news and research reports. The company was founded in 2004, and Xing Zhang has been the CEO of the company since 2004. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Chinese Academy of Social Sciences | College/University | Doctorate Degree | |
Singapore Management University | College/University | Graduate Degree | |
Dongbei University of Finance & Economics | College/University | Corporate Officer/Principal | |
Morgan Stanley Asia Ltd.
![]() Morgan Stanley Asia Ltd. Investment Banks/BrokersFinance Morgan Stanley Asia Ltd. (MSA) is a broker/dealer headquartered in Hong Kong. The firm was founded in 1987 and is a subsidiary of Morgan Stanley (NYSE: MS) in the US. MSA provides institutional securities such as equities, fixed income, derivatives and research. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Chinese Taxation Institute | Director/Board Member | ||
JULONG CO.,LTD. | Computer Peripherals | Director/Board Member | |
Merrill Lynch Securities (Taiwan) Ltd.
![]() Merrill Lynch Securities (Taiwan) Ltd. Investment Banks/BrokersFinance Part of Bank of America Corp., Merrill Lynch Securities (Taiwan) Ltd. is a brokerage service provider. The company is based in Taipei, Taiwan. Merrill Lynch Securities (Taiwan was founded in 2008. | Investment Banks/Brokers | Analyst-Equity | |
Evalueserve Business Consulting (Shanghai) Co., Ltd.
![]() Evalueserve Business Consulting (Shanghai) Co., Ltd. Investment ManagersFinance Evalueserve Business Consulting (Shanghai) Co., Ltd. (Evalueserve Shanghai) is an AI-enhanced managed services global provider headquartered in Shanghai, China. The firm was founded in 2005 and is owned by Evalueserve, Inc. in the US. More than 30% of the Fortune 1000, which includes over 25,000 platform users, rely on Evalueserve’s intelligence and analytics to strengthen and accelerate decision-making. Their solutions uniquely combine expert services with domain-specific AI and have been recognized by analysts such as Forrester and Chartis. Evalueserve’s solutions include data analytics, insights and advisory, intellectual property and R&D, investment banking services, lending services, private equity services, and risk and compliance. These solutions are powered by Evalueserve’s modular AIRA (AI for Research and Analytics) ecosystem, which includes domain-specific accelerators, products, and platforms. Evalueserve experts use these tools to reduce time to value and integrate new solutions into existing workflows. Notable products and platforms include Insightsfirst, Insightloupe, Publishwise, Spreadsmart, and Compsbuilder. The firm supports three categories of firms: financial services, corporates, and professional services. Specifically, this includes Investment Banks, Corporate and Commercial Banks, Asset and Wealth Management Firms, Private Equity and Venture Capital Firms, Index Providers, Technology and Telecom, Life Sciences and Healthcare, Manufacturing and Industrial Goods, Energy, Chemicals, CPG and Retail, Logistics and Transportation, Professional Service Firms, Consultancy and Advisory Firms, Legal Firms, Real Estate Firms, Education and EdTech Firms. | Investment Managers | Corporate Officer/Principal | |
NEXTEER AUTOMOTIVE GROUP LIMITED | Auto Parts: OEM | Director/Board Member | |
Robins E. Claiborne School of Business | College/University | Undergraduate Degree | |
Shenzhen Baishitong Technology Development Co., Ltd. | Director/Board Member Director/Board Member | ||
Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd.
![]() Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd. engages in the research, development, production, and operation of new bioengineered drugs, genetically engineered vaccines, new pharmaceutical preparations, purified water, and distilled water. The company was founded on March 22, 1999 and is headquartered in Shenzhen, China. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
![]() Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of 3SBio, Inc., Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. is a Chinese bio-pharmaceutical company. The company is based in Dongguan, China. The company was founded in 2011. The CEO is Yong Xu. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
![]() Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Biotechnology | Chairman Director/Board Member | |
Hongkong Sansheng Medical Ltd.
![]() Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Shanghai Hongshang Investment Co., Ltd.
![]() Shanghai Hongshang Investment Co., Ltd. Financial ConglomeratesFinance Shanghai Hongshang Investment Co., Ltd. operates as an investment holding company. Its business activities include industrial investment, investment management and consultation, asset management, and import and export business. The company was founded on November 5, 2015 and is headquartered in Shanghai, China. | Financial Conglomerates | Chief Executive Officer | |
HSBC Qianhai Securities Ltd.
![]() HSBC Qianhai Securities Ltd. Investment Banks/BrokersFinance HSBC Qianhai Securities Ltd. combines the global platform of HSBC Group with the local resources of Qianhai Financial Holdings to provide clients with a comprehensive range of securities products and services. HSBC Qianhai Securities is based in Shenzhen, CN. The Chinese company is committed to providing professional, diverse, and customized wealth management services to high-net-worth and ultra-high-net-worth clients and their families. With a global perspective, the company has insights into the Chinese A-share market. The joint venture company was founded in 2017, and the CEO is Irene Ho. | Investment Banks/Brokers | Analyst-Equity | |
Strategic International Group Ltd.
![]() Strategic International Group Ltd. Miscellaneous Commercial ServicesCommercial Services Strategic International Group Ltd. Provides financial services. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Guangdong Sunshine Pharmaceutical Co., Ltd.
![]() Guangdong Sunshine Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2016, Guangdong Sunshine Pharmaceutical Co., Ltd. is a subsidiary of 3SBio, Inc. that manufactures and markets biopharmaceutical products. The company is based in Dongguan, China. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Zhejiang Haichang Bio-Tech Co., Ltd.
![]() Zhejiang Haichang Bio-Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Haichang Bio-Tech Co., Ltd. is a national high-tech enterprise located in Hangzhou, China. The Chinese company specializes in research and development of biopharmaceutical technology, with independent innovation capabilities and global intellectual property rights. It was founded in 2013 by Xiao Bin Zhao. | Pharmaceuticals: Major | Director/Board Member | |
Focus&Fusion Healthcare (Hangzhou) Co., Ltd.
![]() Focus&Fusion Healthcare (Hangzhou) Co., Ltd. Medical SpecialtiesHealth Technology Focus & Fusion Healthcare Co. Ltd. is a Chinese company that manufactures clinical diagnostic equipment. The company is located in China. | Medical Specialties | Director/Board Member | |
Liaoning Sunshine Bio-Pharmaceutical Co., Ltd. | Chief Executive Officer Director/Board Member | ||
Liaoning Sunshine Science & Technology Development Co. Ltd. | Chief Executive Officer Director/Board Member | ||
SUZHOU ZELGEN BIOPHARMACEUTICALS CO.,LTD. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
Cina | 33 |
Hong Kong | 10 |
Stati Uniti | 4 |
Taiwan | 3 |
Isole Cayman | 2 |
Settori
Finance | 22 |
Health Technology | 10 |
Consumer Services | 9 |
Non-Energy Minerals | 3 |
Utilities | 2 |
Posizioni
Analyst-Equity | 112 |
Director/Board Member | 67 |
Independent Dir/Board Member | 26 |
Corporate Officer/Principal | 12 |
Chairman | 11 |
Contatti più connessi
Insiders | |
---|---|
Jing Lou | 25 |
Zhen Ping Zhu | 12 |
Dong Mei Su | 11 |
Wei Zhang | 11 |
Bin Wang | 9 |
Yan Li Liu | 8 |
Fan Zhi Huang | 7 |
Guo Qiang Ma | 7 |
Ji Zhang | 6 |
Edward Du | 5 |
Cheryl Wen | 5 |
Mark Yuan | 5 |
Sky Hong | 4 |
Nora Min | 4 |
Phyllis Wang | 4 |
- Borsa valori
- Insiders
- Feng Zhan Zhang
- Connessioni Società